Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life.
Zhang B, Gollapudi D, Gorman J, O'Dell S, Damron LF, McKee K, Asokan M, Yang ES, Pegu A, Lin BC, Chao CW, Chen X, Gama L, Ivleva VB, Law WH, Liu C, Louder MK, Schmidt SD, Shen CH, Shi W, Stein JA, Seaman MS, McDermott AB, Carlton K, Mascola JR, Kwong PD, Lei QP, Doria-Rose NA.
Zhang B, et al. Among authors: ivleva vb.
Sci Rep. 2022 Oct 25;12(1):17876. doi: 10.1038/s41598-022-22435-2.
Sci Rep. 2022.
PMID: 36284200
Free PMC article.